<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Correvio Pharma Corp.

    Correvio Pharma Corp.

    Correvio has two marketed, in-hospital, cardiology products: BRINAVESSÂŽ (vernakal...

    Correvio has two marketed, in-hospital, cardiol...

    Filing Type:    PU
    Recro Pharma, Inc.

    Recro Pharma, Inc.

    Recro Pharma (NASDAQ: REPH) is a revenue generating specialty pharmaceutical compa...

    Recro Pharma (NASDAQ: REPH) is a revenue genera...

    Filing Type:    PU
    Entera Bio Ltd.

    Entera Bio Ltd.

    Entera Bio is a clinical-stage biopharmaceutical company focused on the developmen...

    Entera Bio is a clinical-stage biopharmaceutica...

    Filing Type:    PU
    Ocugen, Inc.

    Ocugen, Inc.

    Ocugen is a clinical stage biopharmaceutical company focused on discovering, devel...

    Ocugen is a clinical stage biopharmaceutical co...

    Filing Type:    PU
    Roche Holding Ltd

    Roche Holding Ltd

    Together, a potent new drug and a blood test to guide its use can be a life change...

    Together, a potent new drug and a blood test to...

    Filing Type:    PU
    Atara Biotherapeutics, Inc.

    Atara Biotherapeutics, Inc.

    Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy ...

    Atara Biotherapeutics is a leading off-the-shel...

    Filing Type:    PU
    Bicycle Therapeutics plc

    Bicycle Therapeutics plc

    Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a no...

    Bicycle Therapeutics is a clinical-stage biopha...

    Filing Type:    PU
    BeiGene, Ltd.

    BeiGene, Ltd.

    BeiGene, Ltd. (“BeiGene”) is a commercial-stage biotechnology company focused ...

    BeiGene, Ltd. (“BeiGene”) is a commercial-s...

    Filing Type:    PU
    Heron Therapeutics, Inc.

    Heron Therapeutics, Inc.

    Our mission is to improve the lives of patients by developing novel, best-in-class...

    Our mission is to improve the lives of patients...

    Filing Type:    PU
    Dynavax Technologies Corporation

    Dynavax Technologies Corporation

    Dynavax Technologies Corporation (Nasdaq: DVAX) is a clinical-stage biopharmaceuti...

    Dynavax Technologies Corporation (Nasdaq: DVAX)...

    Filing Type:    PU
    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to im...

    Five Prime Therapeutics, Inc. discovers and dev...

    Filing Type:    PU
    Akari Therapeutics Plc

    Akari Therapeutics Plc

    Akari is a biopharmaceutical company focused on developing inhibitors of acute and...

    Akari is a biopharmaceutical company focused on...

    Filing Type:    PU
    ©2024 National Investor Network. All Rights Reserved.